This Supplement was recently discussed on the blog in an entry entitled;
"Warning Miracle Mineral Solution: ITS BACK"
by di-ve.com - editorial@di-ve.com
Local News -- 04 January 2011 -- 14:55CEST
The Public Health Regulation Department has issued a health warning on an oral mineral supplement available for sale online, stating that the product was dangerous and led to adverse effects.
The product in question is named Miracle Mineral Solution, available for sale in Europe and over the internet. Another related product, called MMS2, comes in the form of capsules.
The product’s website includes a number of grandiose claims, stating that “the answer to AIDS, hepatitis A,B and C, malaria, herpes, TB, most cancer and many more of mankind's worse diseases has been found.”
But these claims are scientifically unsubstantiated; and worse still, a number of adverse effects have been reported.
It contains a 28 per cent sodium chlorite solution which is equivalent to industrial-strength bleach, and if taken as directed, could cause severe nausea, vomiting and diarrhoea potentially leading to dehydration and reduced blood pressure, the PHRD said.
The effects could be worse if the solution is directed less than instructed, possibly causing damage to the intestines and to the blood cells and potentially resulted in kidney failure.
The department said that 1 death associated with the use of the product had been reported by the media, although it could not be officially confirmed.
It thus advised the public not to procure such a product, or to throw away any they had purchased. People who have consumed the product and feel unwell should consult their doctor.
“The department once again reminds the public that the quality, safety and efficacy of products bought over the internet cannot be always be guaranteed and advises the public not to engage in such an activity where medicinal products are concerned,” the department concluded.
http://www.di-ve.com/Default.aspx?ID=72&Action=1&NewsId=79992
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment